Institutional investors purchased a net $75.2 million shares of PFE during the quarter ended March 2016 and now own 75.95% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOLDMAN SACHS & CO. (PRIVATE BAN... Bought 56.0 Million shares of Pfizer
T. ROWE PRICE ASSOCIATES, INC. Bought 23.8 Million shares of Pfizer
MANAGED ACCOUNT ADVISORS LLC Bought 13.1 Million shares of Pfizer